Latest It Services News

GR Engineering Services has been named preferred contractor for Brightstar Resources’ Laverton Processing Plant, a major 1.5 Mtpa gold facility in Western Australia, pending final investment and funding decisions.

Djerriwarrh Investments and Australian Foundation Investment Company announce a major leadership change as Mark Freeman retires and Alison Gibson steps in as CEO and Managing Director.

Brightstar Resources has appointed GR Engineering as the preferred EPC contractor for its Goldfields processing plant near Laverton, advancing towards first gold production by June 2027. The company is progressing debt financing and equity raising to fund development, supported by a robust updated feasibility study.

Australian Foundation Investment Company (AFIC) announces the retirement of long-serving CEO Mark Freeman and the appointment of Alison Gibson as his successor, marking a significant leadership transition for the $12 billion investment firm.

Centrepoint Alliance reports a 17% rise in normalised EBITDA for H1 FY26 and announces a strategic divestment of its lending aggregation business to Astute Financial Management, expected to boost annual EBITDA by $0.4 million from FY27.

Asset Vision Co Limited reported a 27% increase in revenue to $3.06 million for the half-year ended December 2025, yet recorded a net loss of $54,052 due to deliberate investments in growth and product development.

Acrow Limited reaffirms its first half FY26 revenue guidance with a 22% increase year-on-year, driven by robust demand in key Australian regions and strategic capital investments.

MLG Oz Limited reported a robust HY2026 with statutory net profit after tax soaring 73.2% to $7.1 million, driven by strong demand in the gold sector and operational resilience despite early weather setbacks and a safety fine.

MLG Oz Limited has delivered a robust half-year performance with revenue climbing 6% and EBITDA soaring 24.5%, underpinned by strong gold sector demand and operational efficiencies.

MLG Oz Limited reported a robust half-year with revenue up 5.3% to $287.2 million and net profit soaring 73.3% to $7.1 million, overcoming early weather disruptions and a significant safety fine.

Rhythm Biosciences has inked a non-exclusive distribution agreement with 4Cyte Pathology to integrate its ColoSTAT® colorectal cancer blood test into a vast pathology network across eastern Australia, aiming to boost adoption and accessibility.

SEEK Limited has reported a robust first half for FY2026, driven by AI-enhanced products and strategic pricing, resulting in double-digit revenue growth and a record interim dividend.